Scientists have taken a first step toward improving those problematic PSA tests for prostate cancer, by mixing in some genetic information that might help tell which men really need a biopsy. The ...

A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients. The study published ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Mar. 23 -- FRIDAY, June 1 (HealthDay News) -- A protein that is used as a marker of heart disease may also predict survival odds and response to chemotherapy for men with advanced prostate cancer.

Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

Until recently, the treatment of metastatic castration-resistant prostate cancer (mCRPC) relied exclusively on hormonal therapies and taxane chemotherapy. The advent of modern molecular profiling ...

The Scottish Prostate Cancer Initiative launches free PSA tests for 25,000 men aged 40–80, aiming to boost early prostate ...